[{"uuid": "ea2caa58-3626-35e5-9982-23caf587fa18", "title": "After Plunging -5.28% in 4 Weeks, Here's Why the Trend Might Reverse for California Resources (CRC)", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/plunging-5-28-4-weeks-143507066.html", "providerPublishTime": 1738593307, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XxozWWpdDFgGg6m0CzltLg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 900, "height": 602, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HGBb_w3iAqceoCyVMucmoA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRC"]}, {"uuid": "89cd2b87-90b7-3aab-bd66-ac8d1413d982", "title": "Pfizer\u2019s BRAFTOVI\u00ae Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/pfizer-braftovi-combination-regimen-significantly-114500758.html", "providerPublishTime": 1738583100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/yM5fUOPKEgQLtgQhPqvsIw--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ad5f5c054042493765996baf5af354f0", "width": 480, "height": 212, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/RwDwsG5Sogq_Hiohe5dNyQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/ad5f5c054042493765996baf5af354f0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE"]}, {"uuid": "72d22a89-35b0-383e-8a08-223a114fa65b", "title": "Q4 2024 AbbVie Inc Earnings Call", "publisher": "Thomson Reuters StreetEvents", "link": "https://finance.yahoo.com/news/q4-2024-abbvie-inc-earnings-062602319.html", "providerPublishTime": 1738391162, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "76a4f3c8-01af-3344-ae70-88dc7cd66b90", "title": "AbbVie (ABBV) Q4 2024 Earnings Call Transcript", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/76a4f3c8-01af-3344-ae70-88dc7cd66b90/abbvie-%28abbv%29-q4-2024.html", "providerPublishTime": 1738349112, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/AgPxjmk.l0_x4qaFILkqiQ--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73", "width": 400, "height": 427, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oVP_Q9NIziRyCtD.nB7xKw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV"]}, {"uuid": "31630965-cf1b-39a1-9c1d-ce0ced3c4044", "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo\u00ae (nivolumab) plus Yervoy\u00ae (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-115900977.html", "providerPublishTime": 1738324740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JRtyzBadqE1Nq.uHIWMUwQ--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 1497, "height": 206, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WJy8uojPrXdfK6vNe_ylZw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT"]}, {"uuid": "e12f0b9d-04a3-3d0b-b6e9-d8d5c336a3f1", "title": "California Resources Corporation Announces $100,000 Donation\u00a0to Southern California Wildfire Relief and Recovery Efforts", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/california-resources-corporation-announces-100-185000266.html", "providerPublishTime": 1738263000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Pu9mlWBhVbfRiOZEVvjYfw--~B/aD03NDM7dz0yNTUwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/730255a43ce278cc5cb6fd35daab46bc", "width": 2550, "height": 743, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/lV3LFqr0Ja9jq_9ZP9BpQQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/730255a43ce278cc5cb6fd35daab46bc", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CRC"]}, {"uuid": "7c1cc010-c30d-30a6-b722-47754f873dde", "title": "Onco-Innovations' Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/onco-innovations-licensed-technology-shows-220000327.html", "providerPublishTime": 1738274400, "type": "STORY", "relatedTickers": ["ONNVF"]}, {"uuid": "ba008e50-b729-3533-bf77-c35a7098fb72", "title": "Elastos secures $20 million investment to expand Bitcoin DeFi ecosystem", "publisher": "TheStreet", "link": "https://finance.yahoo.com/m/ba008e50-b729-3533-bf77-c35a7098fb72/elastos-secures-%2420-million.html", "providerPublishTime": 1738261836, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Wsj.qzMgUH1EtwuWp3ssgA--~B/aD04MDA7dz0xMDY3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/cac8ed6a8a3a8b84f09b3b8377dce593", "width": 1067, "height": 800, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mhYptB_LDPZiJxALRx16kA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/cac8ed6a8a3a8b84f09b3b8377dce593", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "3d6a724f-727e-3527-89e5-504b653f5b94", "title": "Clinical Studies Conducted at Florida Cancer Specialists & Research Institute Expanding Treatment Options and Improving Outcomes for Patients with Gastrointestinal and Genitourinary Cancers", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/clinical-studies-conducted-florida-cancer-155700145.html", "providerPublishTime": 1738252620, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/MDGpNGA2sfQ74gDJevnhSA--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/125426cf17ec91460e3a45ee597fbae7", "width": 400, "height": 209, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YSdN8Ry.5tnNmVtR61rsbA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/125426cf17ec91460e3a45ee597fbae7", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "c6079fa0-3a9c-3105-99a7-eae6fbb94b3e", "title": "What's in Store for Suncor Energy Stock in Q4 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/whats-store-suncor-energy-stock-114900060.html", "providerPublishTime": 1738237740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XZlfIZsWv4Zk8B16YMQW3g--~B/aD0zNjA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 620, "height": 360, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/basziZN2oibsd7YoTsUvFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["SU"]}, {"uuid": "0e0913fe-ea36-33a9-83b4-66988e88f75d", "title": "Bet on Energy With 4 U.S. Upstream Oil & Gas Stocks", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bet-energy-4-u-upstream-135300445.html", "providerPublishTime": 1738158780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9InfUzAtiM9j21eIuxM3Yw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1ebb4d9acd53bae23e286c2bf787a03a", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/PkU9_UMFnqxFHkt94u9SNA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1ebb4d9acd53bae23e286c2bf787a03a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["^GSPC", "LNG", "EOG", "CRC"]}, {"uuid": "d5f7bb34-8770-3721-93e4-2d4a302cca88", "title": "Government of Canada modernizes disaster recovery funding program", "publisher": "CNW Group", "link": "https://finance.yahoo.com/news/government-canada-modernizes-disaster-recovery-151800390.html", "providerPublishTime": 1738163880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Z6LCGsELKlqa.QgHoq7q6A--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cnwgroup.com/133a12593780b49cb323aa13ec301ad9", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ub3nYtkSpl_MZ4PwBb8EGg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cnwgroup.com/133a12593780b49cb323aa13ec301ad9", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "9000ac92-a0cf-39b2-8e54-4b000bbcb612", "title": "Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dewpoint-therapeutics-announces-dptx3496-development-130000457.html", "providerPublishTime": 1738155600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dGmO279kHVvTWLKfx8KvcA--~B/aD0xMTg0O3c9MjI2MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b481129563813a7b3a3cf6e8017b2aa0", "width": 2262, "height": 1184, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1oGOgmn8IZfpGUx.as5T_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b481129563813a7b3a3cf6e8017b2aa0", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "f1872b88-a726-3dcd-b3b9-2dbff097d6dd", "title": "Helmerich & Payne to Post Q1 Earnings: Here's What to Expect", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/helmerich-payne-post-q1-earnings-122900528.html", "providerPublishTime": 1738153740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dRSMcf84zfug8HxTqbPlnQ--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d8480336f9aa68df0c3fc385bf640cf9", "width": 620, "height": 349, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HkICCEagW2xgyLXIrvTVvg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d8480336f9aa68df0c3fc385bf640cf9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HP"]}, {"uuid": "427496ca-32c2-3525-a83c-4f6743333762", "title": "What's in Store for Marathon Petroleum Stock in Q4 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/whats-store-marathon-petroleum-stock-111500810.html", "providerPublishTime": 1738149300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XZlfIZsWv4Zk8B16YMQW3g--~B/aD0zNjA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 620, "height": 360, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/basziZN2oibsd7YoTsUvFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9137c6f6ed305652874fd6a3a724cf37", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MPC"]}, {"uuid": "2da78331-75bc-329b-9497-7ebfd871e40e", "title": "Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/leap-therapeutics-reports-initial-clinical-120000712.html", "providerPublishTime": 1738065600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/C97iwlMJ_.mZUFTbQfAyeA--~B/aD0xMTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/8dc795371648bf5b4f6c87c19d7aa633", "width": 400, "height": 115, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zUf6of9n03Ue6KUeGAKQFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/8dc795371648bf5b4f6c87c19d7aa633", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["LPTX"]}, {"uuid": "59f1a5dc-3469-303d-aaf5-20060d365f13", "title": "Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/persephone-biosciences-announces-full-enrollment-140000630.html", "providerPublishTime": 1738072800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4f0oSNr5BgV8IrpPLH36hQ--~B/aD03NDt3PTQ5MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5e69123fa4c3d595b0f970d6da9ac681", "width": 491, "height": 74, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sxFYZPyKM38eXFA4F3RCpw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5e69123fa4c3d595b0f970d6da9ac681", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "d190fcb2-ab47-3904-b987-ed8401d3ba65", "title": "AmMax Bio Announces First Patient Dosed in Phase 2a Study Evaluating\u00a0AMB-066 in Patients with Colorectal Cancer Minimal Residual Disease", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/ammax-bio-announces-first-patient-130000419.html", "providerPublishTime": 1737982800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9igJGcdXYFsEoRKF2LD80A--~B/aD03MTk7dz0xODc1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/46f804a35738b6392ef895a4541eb172", "width": 1875, "height": 719, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ahf9S5dVbqS6w6qCL52o_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/46f804a35738b6392ef895a4541eb172", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "e1ab1ccc-50a8-30ff-a260-6f95c5b96bb8", "title": "Exelixis Stock Falls as Oppenheimer Downgrades Rating to Perform", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/exelixis-stock-falls-oppenheimer-downgrades-173600222.html", "providerPublishTime": 1737999360, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1hcqAcr._xcksqqDo_WNwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EXEL"]}, {"uuid": "0c9c26d5-0c69-3665-b0a6-203d9e1f81f4", "title": "Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA\u00ae (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/adagene-announces-updated-data-phase-120000235.html", "providerPublishTime": 1737979200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SRx5f7krxeAhjFPZcihDaA--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fe1e492df597a586d8304ad7fbea4a8b", "width": 440, "height": 386, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TIUtNJ3HDvqIb71D1MsA5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/fe1e492df597a586d8304ad7fbea4a8b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ADAG"]}]